Gyre Therapeutics (GYRE) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Gyre Therapeutics (GYRE) over the last 16 years, with Q3 2025 value amounting to 0.69.
- Gyre Therapeutics' Asset Utilization Ratio fell 1943.08% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year decrease of 1943.08%. This contributed to the annual value of 0.87 for FY2024, which is 2244.42% down from last year.
- As of Q3 2025, Gyre Therapeutics' Asset Utilization Ratio stood at 0.69, which was down 1943.08% from 0.72 recorded in Q2 2025.
- In the past 5 years, Gyre Therapeutics' Asset Utilization Ratio ranged from a high of 16.8 in Q3 2023 and a low of 0.05 during Q2 2021
- Its 5-year average for Asset Utilization Ratio is 2.06, with a median of 0.79 in 2025.
- As far as peak fluctuations go, Gyre Therapeutics' Asset Utilization Ratio soared by 2961075.23% in 2023, and later plummeted by 9492.03% in 2024.
- Quarter analysis of 5 years shows Gyre Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then surged by 1515.85% to 1.77 in 2022, then grew by 1.5% to 1.79 in 2023, then tumbled by 52.95% to 0.84 in 2024, then decreased by 18.53% to 0.69 in 2025.
- Its Asset Utilization Ratio stands at 0.69 for Q3 2025, versus 0.72 for Q2 2025 and 0.79 for Q1 2025.